ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Delivery of gefitinib with an immunostimulatory nanocarrier improves therapeutic efficacy in lung cancer

Diao, Dingwei; Zhai, Jianxue; Yang, Jianjun; Wu, Hua; Jiang, Jianjun; Dong, Xiaoying; Passaro, Antonio; Aramini, Beatrice; Rao, Shuan*; Cai, Kaican*南方医科大学
Translational Lung Cancer Research2021-2DOI: 10.21037/tlcr-21-144
5被引5阅读
引用收藏
分享

摘要

Background: Combining different cancer treatments represents a promising strategy to improve the therapeutic outcome for lung cancer patients with or without druggable gene alterations. @@@ Methods: We previously developed a polyethylene glycol-based (PEG-based) immunostimulatory nanocarrier (PEG2k-Fmoc-NLG919) which can efficiently co-deliver an indoleamine 2,3-dioxygenase-1 (IDO1) inhibitor and the chemotherapeutic agent, paclitaxel. This method was found to improve cancer therapy by simultaneously performing immunoand chemo-therapy. However, whether this nanocarrier could deliver targeted drugs to implement targeted therapy together with immunotherapy remains unclear. @@@ Results: Here, we report that the delivery of the classical tyrosine kinase inhibitor (TKI), gefitinib, with the optimized PEG5k-Fmoc-NLG919 nanocarrier, increased the sensitivity of lung cancer cells to gefitinib in vitro. Gefitinib was gradually but sufficiently released from the nanocarrier with comparable capacity to inhibit epidermal growth factor receptor (EGFR) activity as using free gefitinib directly. More importantly, treatment with gefitinib-loaded PEG5k-Fmoc-NLG919 could suppress lung tumor development more efficiently than gefitinib alone in vivo by inducing an immune active microenvironment with more functional CD8(+) T cells and less regulatory T cell infiltration. @@@ Conclusions: Our study therefore demonstrates that delivery of small molecular targeted drugs with the immunostimulatory nanocarrier is a straightforward strategy for improving antitumor response for lung cancer therapy.

学科与关键词

关键词
Gefitinibnanocarrierimmunostimulatorylung cancer
相关
加载中…
  • A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy
    Xu, Bin; Zeng, Fanjun; Deng, Jialong; Yao, Lintong; Liu, Shengbo; Hou, Hengliang; Huang, Yucheng; Zhu, Hongyuan; Wu, Shaowei; Li, Qiaxuan; Zhan, Weijie; Qiu, Hongrui; Wang, Huili; Li, Yundong; Yang, Xianzhu; Cao, Ziyang*; Zhang, Yu*; Zhou, Haiyu*Bioactive Materials, 2023, 27: 337-347.被引 5
  • An Activatable Nano-Prodrug for Treating Tyrosine-Kinase-Inhibitor-Resistant Non-Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging
    Xie, Xin; Zhan, Chenyue; Wang, Jie; Zeng, Fang*; Wu, Shuizhu*Small, 2020, 16(38): 2003451.被引 22
  • Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung Cancer
    Liu, Meng; Sun, Chuanchuan; Jiang, Jiangle; Wan, Li; Hu, Chong; Wen, Chunping; Huang, Guiju; Ruan, Qiufen; Wu, Shuang; Qiao, Dan; Zheng, Pengwu; Pan, Qingshan*; Zhu, Wufu*ACS Applied Nano Materials, 2023, 6(23): 21587-21602.
查看全部 →

发表信息

论文状态
公开发表
期刊
Translational Lung Cancer Research
发表日期
2021-02
卷期
第 10 卷, 第 2 期
页码
926-935
DOI
10.21037/tlcr-21-144
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University [2020J001]; Southern Medical University

作者

  • D

    Diao, Dingwei (第一作者)

    southern med univ

  • Z

    Zhai, Jianxue

    southern med univ

查看全部 10 位作者收起作者
  • Y

    Yang, Jianjun

    southern med univ

  • W

    Wu, Hua

    southern med univ

  • J

    Jiang, Jianjun

    southern med univ

  • D

    Dong, Xiaoying

    southern med univ

  • P

    Passaro, Antonio

  • A

    Aramini, Beatrice

  • R

    Rao, Shuan (通讯)

    southern med univ

  • C

    Cai, Kaican (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417